The genomic map of breast cancer: which roads lead to better targeted therapies?
Justin M. Balko(Vanderbilt University Medical Center), Carlos L. Arteaga(The University of Texas Southwestern Medical Center)
Cited by 10
Related Papers
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|570
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
|Breast Cancer Research|2011|463
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
|JCI Insight|2018|159